Navigation Links
Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV
Date:10/29/2009

CAMBRIDGE, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that Novartis Pharma AG has decided not to exercise its option to license IDX184, a novel liver-targeted prodrug of 2'-methyl guanosine nucleotide, for the treatment of HCV. As a result, Idenix retains the worldwide rights to develop, commercialize and license IDX184 without any further obligation to Novartis.

"As we continue to develop IDX184, we look forward to seeking a partner that will assist us in maximizing the value of this asset," said Jean-Pierre Sommadossi, Ph.D., chairman and chief executive officer of Idenix.

About IDX184

IDX184 is a novel, liver-targeted 2'-methyl guanosine nucleotide prodrug, which includes Idenix's proprietary liver-targeting technology. This technology enables the delivery of nucleoside monophosphate to the liver, leading to the formation of high levels of nucleoside triphosphate, potentially maximizing drug efficacy and limiting systemic side effects with low, once-daily dosing.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus. For further information about Idenix, please refer to www.idenix.com.

Forward-looking Statements

This press release contains "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
2. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
3. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
4. Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results
5. Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results
6. Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
7. Idenix Pharmaceuticals Reports First Quarter Financial Results
8. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
9. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
10. Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
11. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... (PRWEB) September 17, 2014 Beckman ... advances science and healthcare, has renewed its agreement with ... As part of the agreement, Personify will continue to ... sustained emphasis on recruitment analytics, including time-to-fill, time-to-source and ... renew our agreement with Personify was based on the ...
(Date:9/17/2014)... NASA’s MESSENGER has just celebrated its 10 year ... have one of its latch valves, V27200-818, operating onboard ... investigation of the planet Mercury. It is only the ... provided a vast amount of information and images of ... utilize solenoids that also include permanent magnets to maintain ...
(Date:9/16/2014)... “Nature has developed, very cleverly, some lessons ... in optical design,” said Joseph Shaw, director of the ... explore surfaces and structures at the nanoscale, we’ll discover ... San Diego in August during a conference called “ ... by Shaw and Rongguang Liang of the University of ...
(Date:9/16/2014)... 16, 2014  Biocom, the association representing the ... the 9 th Annual National Health Information Technology ... technologies in improving our health care system. ... of the world,s most vibrant hubs for health IT ... applications to genomic testing to remote patient monitoring," said ...
Breaking Biology Technology:Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3Nature’s designs inspire research into new light-based technologies 2Nature’s designs inspire research into new light-based technologies 3Nature’s designs inspire research into new light-based technologies 4Nature’s designs inspire research into new light-based technologies 5Biocom Recognizes National Health IT Week 2
... Salk Institute is pleased to announce the appointment of ... Salk Institute Office of Technology Development. His appointment begins ... experience in academic technology transfer.  For over a decade ... Patent Foundation, where he led a broad expansion and ...
... Volcano Corporation (Nasdaq: VOLC ), a leading ... to enhance the diagnosis and treatment of coronary and ... to market the Eagle Eye® Platinum digital IVUS catheter ... 20th PCI Live Demonstration Course in Kurashiki, which starts ...
... 2011 Healthzone Limited (ASX: HZL; OTCQX: HLTZY) announced ... The Trout Group LLC ("the Trout Group"), a leading ... Trout Group will provide investor relations services for Healthzone ... With more than 60 current clients, the Trout Group ...
Cached Biology Technology:Salk Welcomes National Leader in Academic Technology Transfer 2Volcano Announces the Introduction of the Eagle Eye® Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki 2Volcano Announces the Introduction of the Eagle Eye® Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki 3Healthzone Limited Engages The Trout Group for Investor Relations Services 2
(Date:9/16/2014)... began on September 13, 2014. The fire is human-caused ... over 2,300 acres in size and is mostly being ... was calm Monday night due to higher humidity. ... and beginning to construct a fireline on the West and ... working on the fire: , 7 20-person Crews, 4 Hot ...
(Date:9/16/2014)... 10-km diameter chunk of rock hit the Yukatan peninsula near ... force of 100 teratons of TNT. It left a crater ... global earthquakes and volcanism are widely accepted to have wiped ... the mammals. But what happened to the plants on which ... from the University of Arizona reveals that the meteorite impact ...
(Date:9/16/2014)... week, its Government could face an uphill challenge in ... has revealed. , The University of Nottingham Shale Gas ... extraction in the UK since March 2012 and has ... the least supportive of fracking. , Professor Sarah O,Hara, ... Geography, said: "The clear move against shale gas extraction ...
Breaking Biology News(10 mins):Meteorite that doomed the dinosaurs helped the forests bloom 2Meteorite that doomed the dinosaurs helped the forests bloom 3Scottish people most sceptical on fracking, survey shows 2Scottish people most sceptical on fracking, survey shows 3
... study shows that personal values that people refuse to disavow, ... in the brain than those values that are willingly sold. ... whether it,s a strong religious belief, a national identity ... process," says Gregory Berns, director of the Center for Neuropolicy ...
... Doctors and researchers of Hospital del Mar and ... describing a new pharmacological resistance to cancer. This new ... (epidermal growth factor receptor) causing resistance to treatment using ... attacks the EGFR. The study proves that, both ...
... RIKEN SPring-8 Center in Harima, Japan have clarified the ... a bacterial enzyme that offers clues on the origins ... importance to fundamental science, the findings provide key insights ... greenhouse gas hundreds of times more potent than carbon ...
Cached Biology News:The price of your soul: How the brain decides whether to 'sell out' 2The price of your soul: How the brain decides whether to 'sell out' 3Identified a cause of resistance to colon cancer treatment 2New study sheds light on evolutionary origin of oxygen-based cellular respiration 2
Anti-Rsk2/MAPKAP Kinase 1b, #0 SK2/MAPKAP K1 beta Smartpool&t 3T3 cell lysate Non-specific Control Pool , #D 1X Universal Buffer...
TNF-R2 (L-20)...
... The PowerEase 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple intuitive ...
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
Biology Products: